Immune Combo Active in Relapsed/Refractory AML
MedPage Today,
Patients with relapsed/refractory acute myeloid leukemia (AML) responded better and lived longer than historical benchmarks…
Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort
Overview of attention for article published in Blood Advances, April 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (94th percentile)
-
High Attention Score compared to outputs of the same age and source (94th percentile)
Mentioned by
- news
- 1 news outlet
- policy
- 1 policy source
- 37 X users
- patent
- 1 patent
- 1 Redditor
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 115 Mendeley